Ambulatory Series: Prostate Cancer Screening and Associated Controversies

Thank you for joining us, today we will be reviewing prostate cancer screening and potential benefits as well as any associated controversies. The main focus of our discussion today revolves around PSA, or prostate-specific antigen. Although  treating prostate cancer at an early stage to avoid long-term consequences, including potential metastatic disease, is important, we must acknowledge that our screening tools are imperfect. We don’t want to diminish the importance of treating an aggressive prostate cancer, but simply want to highlight that screening should not be done without a thorough explanation between you and your patient. Author: Nickolas Coombs, DO Host/Editor: Rob Harmon, DO

There are no comments yet.

Please log in to write the first comment.